A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer

✍ Scribed by Steven J. Cohen; Mark M. Zalupski; Manuel R. Modiano; Paul Conkling; Yehuda Z. Patt; Peg Davis; Robert T. Dorr; Michelle L. Boytim; Evan M. Hersh

• Publisher: Springer
• Year: 2009
• Tongue: English
• Weight: 275 KB
• Volume: 66
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-009-1162-y